The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hemangioblastoma


High impact information on Hemangioblastoma


Chemical compound and disease context of Hemangioblastoma


Biological context of Hemangioblastoma


Anatomical context of Hemangioblastoma


Gene context of Hemangioblastoma


Analytical, diagnostic and therapeutic context of Hemangioblastoma


  1. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Kibel, A., Iliopoulos, O., DeCaprio, J.A., Kaelin, W.G. Science (1995) [Pubmed]
  2. Inhibition of transcription elongation by the VHL tumor suppressor protein. Duan, D.R., Pause, A., Burgess, W.H., Aso, T., Chen, D.Y., Garrett, K.P., Conaway, R.C., Conaway, J.W., Linehan, W.M., Klausner, R.D. Science (1995) [Pubmed]
  3. Differential expression in glioblastoma multiforme and cerebral hemangioblastoma of cytoplasmic proteins that bind two different domains within the 3'-untranslated region of the human glucose transporter 1 (GLUT1) messenger RNA. Tsukamoto, H., Boado, R.J., Pardridge, W.M. J. Clin. Invest. (1996) [Pubmed]
  4. Secondary erythrocytosis due to a cerebellar hemangioblastoma: demonstration of erythropoietin mRNA in the tumor. Trimble, M., Caro, J., Talalla, A., Brain, M. Blood (1991) [Pubmed]
  5. Case 2. Hemangioblastomas: diagnosis of von Hippel-Lindau disease and antiangiogenic treatment with SU5416. Schuch, G., de Wit, M., Höltje, J., Laack, E., Schilling, G., Hossfeld, D.K., Fiedler, W., Scigalla, P., Jacobs, M.S. J. Clin. Oncol. (2005) [Pubmed]
  6. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. Berkman, R.A., Merrill, M.J., Reinhold, W.C., Monacci, W.T., Saxena, A., Clark, W.C., Robertson, J.T., Ali, I.U., Oldfield, E.H. J. Clin. Invest. (1993) [Pubmed]
  7. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function. Krieg, M., Marti, H.H., Plate, K.H. Blood (1998) [Pubmed]
  8. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Zagzag, D., Krishnamachary, B., Yee, H., Okuyama, H., Chiriboga, L., Ali, M.A., Melamed, J., Semenza, G.L. Cancer Res. (2005) [Pubmed]
  9. Paradoxical secondary polycythemia in von Hippel-Lindau patients treated with anti-vascular endothelial growth factor receptor therapy. Richard, S., Croisille, L., Yvart, J., Casadeval, N., Eschwège, P., Aghakhani, N., David, P., Gaudric, A., Scigalla, P., Hermine, O. Blood (2002) [Pubmed]
  10. Induction of alkaline phosphatase activity in cultured human intracranial tumor cells. Takahara, N., Herz, F., Singer, R.M., Hirano, A., Koss, L.G. Cancer Res. (1982) [Pubmed]
  11. Relationship between arterial blood pressure and plasma norepinephrine levels in a patient with neurogenic hypertension. Franklin, S.S., Sowers, J.R., Batzdorf, U. Am. J. Med. (1986) [Pubmed]
  12. Factor VIII related antigen and glial fibrillary acidic protein immunoreactivity in the differential diagnosis of central nervous system hemangioblastomas. Epstein, J.I., White, C.L., Mendelsohn, G. Am. J. Clin. Pathol. (1984) [Pubmed]
  13. Diagnostic value of 201Tl-single-photon emission computerized tomography studies in cases of posterior fossa hemangioblastomas. Kondo, T., Kumabe, T., Maruoka, S., Yoshimoto, T. J. Neurosurg. (2001) [Pubmed]
  14. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors. Prowse, A.H., Webster, A.R., Richards, F.M., Richard, S., Olschwang, S., Resche, F., Affara, N.A., Maher, E.R. Am. J. Hum. Genet. (1997) [Pubmed]
  15. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. Lee, J.Y., Dong, S.M., Park, W.S., Yoo, N.J., Kim, C.S., Jang, J.J., Chi, J.G., Zbar, B., Lubensky, I.A., Linehan, W.M., Vortmeyer, A.O., Zhuang, Z. Cancer Res. (1998) [Pubmed]
  16. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Wizigmann-Voos, S., Breier, G., Risau, W., Plate, K.H. Cancer Res. (1995) [Pubmed]
  17. Somatic mutations in VHL germline deletion kindred correlate with mild phenotype. Wait, S.D., Vortmeyer, A.O., Lonser, R.R., Chang, D.T., Finn, M.A., Bhowmick, D.A., Pack, S.D., Oldfield, E.H., Zhuang, Z. Ann. Neurol. (2004) [Pubmed]
  18. Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system. Gläsker, S., Bender, B.U., Apel, T.W., van Velthoven, V., Mulligan, L.M., Zentner, J., Neumann, H.P. J. Neurol. Neurosurg. Psychiatr. (2001) [Pubmed]
  19. High expression of the Glut1 glucose transporter in human brain hemangioblastoma endothelium. Cornford, E.M., Hyman, S., Black, K.L., Cornford, M.E., Vinters, H.V., Pardridge, W.M. J. Neuropathol. Exp. Neurol. (1995) [Pubmed]
  20. Nestin as a marker for proliferative endothelium in gliomas. Sugawara, K., Kurihara, H., Negishi, M., Saito, N., Nakazato, Y., Sasaki, T., Takeuchi, T. Lab. Invest. (2002) [Pubmed]
  21. Rapid and durable recovery of visual function in a patient with von hippel-lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416. Aiello, L.P., George, D.J., Cahill, M.T., Wong, J.S., Cavallerano, J., Hannah, A.L., Kaelin, W.G. Ophthalmology (2002) [Pubmed]
  22. Clinical and molecular analysis of disseminated hemangioblastomatosis of the central nervous system in patients without von Hippel-Lindau disease. Report of four cases. Weil, R.J., Vortmeyer, A.O., Zhuang, Z., Pack, S.D., Theodore, N., Erickson, R.K., Oldfield, E.H. J. Neurosurg. (2002) [Pubmed]
  23. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Pause, A., Lee, S., Worrell, R.A., Chen, D.Y., Burgess, W.H., Linehan, W.M., Klausner, R.D. Proc. Natl. Acad. Sci. U.S.A. (1997) [Pubmed]
  24. Coexpression of transforming growth factor-alpha and épidermal growth factor receptor in capillary hemangioblastomas of the central nervous system. Reifenberger, G., Reifenberger, J., Bilzer, T., Wechsler, W., Collins, V.P. Am. J. Pathol. (1995) [Pubmed]
  25. Hemangioblastoma of the central nervous system: nature of the stromal cells as studied by the immunoperoxidase technique. Tanimura, A., Nakamura, Y., Hachisuka, H., Tanimura, Y., Fukumura, A. Hum. Pathol. (1984) [Pubmed]
  26. Hormone receptor immunoreactivity in hemangioblastomas and clear cell renal cell carcinomas. Brown, D.F., Dababo, M.A., Hladik, C.L., Eagan, K.P., White, C.L., Rushing, E.J. Mod. Pathol. (1998) [Pubmed]
  27. Fine needle aspiration cytology of hemangioblastoma of the spinal cord. Report of a case with immunocytochemical and ultrastructural studies. Silverman, J.F., Dabbs, D.J., Leonard, J.R., Harris, L.S. Acta Cytol. (1986) [Pubmed]
  28. Unusual ocular presentation of von Hippel-Lindau disease. Valenzuela, A., Druker, H., Malkin, D., Gallie, B., Héon, E. Can. J. Ophthalmol. (2005) [Pubmed]
  29. Renal arteriography in von Hippel-Lindau Diease. Campbell, D.R., Mason, W.F., Standen, J.R. Journal of the Canadian Association of Radiologists. (1978) [Pubmed]
WikiGenes - Universities